Altered Hepatic Transport by Fetal Arsenite Exposure in Diet-Induced Fatty Liver Disease

Synergistic interaction between genetics and disease on pravastatin disposition

(2014) John D. Clarke et al.   JOURNAL OF HEPATOLOGY

Increased Susceptibility to Methotrexate-Induced Toxicity in Nonalcoholic Steatohepatitis

(2014) Rhiannon N. Hardwick et al.   TOXICOLOGICAL SCIENCES

Establishment of Metabolism and Transport Pathways in the Rodent and Human Fetal Liver

(2013) Jamie Moscovitz et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Metabolomic Analysis of the Effects of Chronic Arsenic Exposure in a Mouse Model of Diet-Induced Fatty Liver Disease

(2013) Xue Shi et al.   JOURNAL OF PROTEOME RESEARCH

Arsenic Inhibits Autophagic Flux, Activating the Nrf2-Keap1 Pathway in a p62-Dependent Manner

(2013) A. Lau et al.   MOLECULAR AND CELLULAR BIOLOGY

Prepubertal exposure to arsenic(III) suppresses circulating insulin-like growth factor-1 (IGF-1) delaying sexual maturation in female rats

(2013) Michael P. Reilly et al.   REPRODUCTIVE TOXICOLOGY

The epidemiology, pathogenesis and histopathology of fatty liver disease

(2012) Adam P Levene et al.   HISTOPATHOLOGY

PCB 126 and Other Dioxin-Like PCBs Specifically Suppress Hepatic PEPCK Expression via the Aryl Hydrocarbon Receptor

(2012) Wenshuo Zhang et al.   PLoS One

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mitochondrial uncoupling protein-2 deficiency protects steatotic mouse hepatocytes from hypoxia/reoxygenation

(2011) Zachary P. Evans et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease

(2011) A. D. Lake et al.   DRUG METABOLISM AND DISPOSITION

Alteration of Hepatic but Not Renal Transporter Expression in Diet-Induced Obese Mice

(2011) V. R. More et al.   DRUG METABOLISM AND DISPOSITION

Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease

(2011) R. N. Hardwick et al.   DRUG METABOLISM AND DISPOSITION

Oxidative Stress Is Activated by Free Fatty Acids in Cultured Human Hepatocytes

(2011) Giorgio Soardo et al.   Metabolic Syndrome and Related Disorders

Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice

(2011) Min Tan et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats

(2009) Craig D. Fisher et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Nrf2- and PPARα-Mediated Regulation of Hepatic Mrp Transporters after Exposure to Perfluorooctanoic Acid and Perfluorodecanoic Acid

(2008) Jonathan M. Maher et al.   TOXICOLOGICAL SCIENCES

Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice

(2007) Gavin E. Arteel et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY